Zoetis Inc (ZTS)
176.71
+1.04
(+0.59%)
USD |
NYSE |
Nov 21, 16:00
176.71
0.00 (0.00%)
After-Hours: 20:00
Zoetis Market Cap: 79.73B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 79.73B |
| November 20, 2024 | 79.26B |
| November 19, 2024 | 79.21B |
| November 18, 2024 | 79.59B |
| November 15, 2024 | 79.02B |
| November 14, 2024 | 78.79B |
| November 13, 2024 | 79.87B |
| November 12, 2024 | 78.48B |
| November 11, 2024 | 79.47B |
| November 08, 2024 | 79.77B |
| November 07, 2024 | 78.62B |
| November 06, 2024 | 76.86B |
| November 05, 2024 | 79.08B |
| November 04, 2024 | 79.04B |
| November 01, 2024 | 82.09B |
| October 31, 2024 | 80.66B |
| October 30, 2024 | 82.52B |
| October 29, 2024 | 81.85B |
| October 28, 2024 | 82.53B |
| October 25, 2024 | 81.28B |
| October 24, 2024 | 81.96B |
| October 23, 2024 | 85.34B |
| October 22, 2024 | 85.57B |
| October 21, 2024 | 85.55B |
| October 18, 2024 | 87.28B |
| Date | Value |
|---|---|
| October 17, 2024 | 86.25B |
| October 16, 2024 | 87.80B |
| October 15, 2024 | 86.87B |
| October 14, 2024 | 86.99B |
| October 11, 2024 | 85.83B |
| October 10, 2024 | 85.92B |
| October 09, 2024 | 85.87B |
| October 08, 2024 | 84.61B |
| October 07, 2024 | 84.57B |
| October 04, 2024 | 85.81B |
| October 03, 2024 | 86.24B |
| October 02, 2024 | 86.91B |
| October 01, 2024 | 87.79B |
| September 30, 2024 | 88.22B |
| September 27, 2024 | 88.26B |
| September 26, 2024 | 88.29B |
| September 25, 2024 | 86.77B |
| September 24, 2024 | 87.75B |
| September 23, 2024 | 87.71B |
| September 20, 2024 | 87.28B |
| September 19, 2024 | 87.55B |
| September 18, 2024 | 89.02B |
| September 17, 2024 | 88.67B |
| September 16, 2024 | 88.01B |
| September 13, 2024 | 86.57B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
44.03B
Minimum
Mar 23 2020
116.88B
Maximum
Dec 29 2021
79.69B
Average
78.91B
Median
Market Cap Benchmarks
| Pfizer Inc | 142.41B |
| Regeneron Pharmaceuticals Inc | 81.81B |
| Vertex Pharmaceuticals Inc | 115.98B |
| Alnylam Pharmaceuticals Inc | 31.83B |
| Biomarin Pharmaceutical Inc | 12.09B |
Market Cap Related Metrics
| PE Ratio | 33.22 |
| PS Ratio | 8.826 |
| PEG Ratio | 4.086 |
| Price to Book Value | 15.23 |
| Price to Free Cash Flow | 35.00 |
| Price | 176.71 |
| Earnings Yield | 3.01% |
| PEGY Ratio | 3.647 |
| Operating PE Ratio | 24.21 |
| Normalized PE Ratio | 31.57 |